A new report explores the challenges med-tech companies face in broadening their reach and identifies strategies to bring high-quality products and services to more patients.
The Essential Drug System (EDS) is one of five priorities that support the government’s overall healthcare reform objective.
The Chinese pharmaceutical market has emerged as a major driver of revenue growth for global pharmaceutical companies.
China’s healthcare sector continues to develop at an astonishing rate, but challenges remain.
Recent health care reforms open the door to insurers, hospitals, and IT vendors.